This specificity might be explained by the following: (1) in cancer cells, usually there is upregulation of proteins that are involved in iron uptake, such as transferrin receptor 1 (TfR1), but downregulation of iron efflux proteins, such as ferroportin.8 This reprogramming of iron metabolism results in enhanced iron influx in cancer cells. The gene discussed is SLC40A1; the disease is cancer.